Arwood, M J <br/><br/>
Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  May 2017 
 - 675-683 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1002/cpt.558  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Alleles<br/>Anticoagulants--administration & dosage<br/>Cytochrome P-450 CYP2C9--genetics<br/>Dose-Response Relationship, Drug<br/>Endpoint Determination<br/>Female<br/>Genotype<br/>Humans<br/>Male<br/>Middle Aged<br/>Pharmacogenetics<br/>Vitamin K Epoxide Reductases--genetics<br/>Warfarin--administration & dosage